Effects of Coca-Cola Zero Sugar Consumption on Urinary Metabolites in Healthy Adults
Metabolic Profiling of Acesulfame Potassium After Coca-Cola Zero Sugar Consumption in Healthy Adults
1 other identifier
interventional
10
1 country
1
Brief Summary
Consumption of beverages containing non-nutritive sweeteners has increased worldwide, but limited information is available regarding the short-term urinary excretion of acesulfame potassium (Ace-K) and the acute metabolic response following consumption of commercially available beverages. This study investigates the urinary pharmacokinetics of Ace-K and the acute urinary metabolomic response after consumption of 500 mL of Coca-Cola Zero Sugar in healthy adults. Participants complete two study arms under free-living conditions: Coca-Cola Zero Sugar and still water (control), separated by a one-month washout period. Urine samples are collected before beverage consumption and repeatedly over the subsequent 24 hours. Proton nuclear magnetic resonance (¹H NMR) spectroscopy is used to quantify Ace-K and other urinary metabolites. The study aims to determine the urinary appearance and elimination kinetics of Ace-K and to identify metabolic changes associated with Coca-Cola Zero Sugar consumption compared with water.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
July 3, 2026
CompletedFirst Posted
Study publicly available on registry
July 10, 2026
CompletedJuly 23, 2026
July 1, 2026
10 months
July 3, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Creatinine-normalized urinary acesulfame potassium (Ace-K) concentration (µM/mM creatinine)
Quantitative measurement of urinary acesulfame potassium (Ace-K) concentration following consumption of 500 mL Coca-Cola Zero Sugar and still water, determined by quantitative proton nuclear magnetic resonance (¹H NMR) spectroscopy. Concentrations will be normalized to urinary creatinine and reported at each scheduled urine collection time point.
Baseline and each scheduled urine collection over 24 hours following beverage consumption.
Secondary Outcomes (1)
Creatinine-normalized urinary metabolite concentrations (µM/mM creatinine)
Baseline and each scheduled urine collection over 24 hours following beverage consumption.
Other Outcomes (2)
Area under the urinary acesulfame potassium concentration-time curve (AUC₀-₂₄)
Up to 24 hours after beverage consumption
Concentrations of selected constituents in Coca-Cola Zero Sugar (µg/mL)
Prior to participant consumption (baseline beverage characterization)
Study Arms (2)
Coca-Cola Zero Sugar
EXPERIMENTALParticipants consumed 500 mL of Coca-Cola Zero Sugar with breakfast. Spot urine samples were collected before beverage consumption and repeatedly over the subsequent 24-hour period for metabolomic and pharmacokinetic analyses using proton nuclear magnetic resonance (¹H NMR) spectroscopy.
Still Water
ACTIVE COMPARATORParticipants consumed 500 mL of still water with breakfast following a one-month washout period. Spot urine samples were collected before beverage consumption and repeatedly over the subsequent 24-hour period using the same sampling schedule as the Coca-Cola Zero Sugar arm.
Interventions
Participants consumed a single oral dose of 500 mL Coca-Cola Zero Sugar with breakfast. The intervention beverage was consumed within approximately 10-20 minutes. Spot urine samples were collected before consumption and repeatedly over the subsequent 24-hour period for metabolomic and pharmacokinetic analyses using proton nuclear magnetic resonance (¹H NMR) spectroscopy.
Participants consumed a single oral dose of 500 mL still water with breakfast under otherwise comparable conditions following a one-month washout period. Spot urine samples were collected before consumption and repeatedly over the subsequent 24-hour period using the same sampling schedule as the intervention arm.
Eligibility Criteria
You may qualify if:
- Healthy adults aged 18 to 60 years
- Able and willing to provide written informed consent
- Willing to consume 500 mL of Coca-Cola Zero Sugar and 500 mL of still water during separate study periods
- Willing to collect urine samples before and during the 24 hours after each intervention according to the study instructions
- Willing to avoid foods and beverages containing non-nutritive sweeteners for 48 hours before each study period
You may not qualify if:
- Younger than 18 years or older than 60 years
- Current smoker
- Known kidney disease or metabolic disease
- Regular use of prescription medications
- Use of antibiotics in last 3 months
- Consumption of foods or beverages containing non-nutritive sweeteners within 48 hours before either study period
- Unable or unwilling to comply with the study procedures or urine collection schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Czech University of Life Sciences Prague
Suchdol, Prague, 16500, Czechia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 3, 2026
First Posted
July 10, 2026
Study Start
September 1, 2023
Primary Completion
June 15, 2024
Study Completion
September 30, 2024
Last Updated
July 23, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available. De-identified data may be considered for sharing upon reasonable request to the study investigators, subject to institutional policies, ethical approval, and applicable data protection regulations.